Craig A. Collard

Companies

• HERON THERAPEUTICS, INC. /DE/Chief executive officer Apr 5, 2023 to now¹
• HERON THERAPEUTICS, INC. /DE/Board member Mar 2, 2023 to now²
• TerrAscend Corp.Board member Jan 10, 2022 to now³
• OPIANT PHARMACEUTICALS, INC.Board member Oct 31, 2018 to Mar 3, 2023⁴
• Sierra Oncology, Inc.Board member May 29, 2020 to Jul 1, 2022⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTerrAscend Corp. TSNDF1,076,538 shares⁶$538.3K at $0.50Jun 24, 2025
• HTHERON THERAPEUTICS, INC. /DE/ HRTX856,492 shares⁷$325.5K at $0.38Jul 31, 2026
• SOSierra Oncology, Inc.0 shares⁸Jul 1, 2022
• OPOPIANT PHARMACEUTICALS, INC.0 shares⁹Mar 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 31, 2026Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/⁷
• Jul 30, 2026Exercised options 50,021 shares of HERON THERAPEUTICS, INC. /DE/⁷
• Jul 19, 2026Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/¹⁰
• Apr 30, 2026Exercised options 50,021 shares of HERON THERAPEUTICS, INC. /DE/¹¹
• Apr 30, 2026Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/¹¹
• Apr 19, 2026Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/¹²
• Apr 3, 2026Exercised options 62,500 shares of HERON THERAPEUTICS, INC. /DE/¹³
• Jan 31, 2026Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/¹⁴
• Jan 19, 2026Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/¹⁵
• Oct 31, 2025Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/¹⁶
• Oct 19, 2025Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/¹⁷
• Jul 31, 2025Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/¹⁸
• Jul 19, 2025Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/¹⁹
• Jun 24, 2025Granted 433,653 shares of TerrAscend Corp.⁶
• Apr 30, 2025Exercised options 34,789 shares of HERON THERAPEUTICS, INC. /DE/²⁰
• Apr 19, 2025Exercised options 13,796 shares of HERON THERAPEUTICS, INC. /DE/²¹
• Apr 3, 2025Exercised options 62,500 shares of HERON THERAPEUTICS, INC. /DE/²²
• Mar 25, 2025Shares withheld for tax 2,258 shares at $0.46 of TerrAscend Corp.²³
• Jan 19, 2025Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/²⁴
• Dec 31, 2024Shares withheld for tax 71,704 shares at $0.65 of TerrAscend Corp.²⁵
• Oct 19, 2024Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/²⁶
• Jul 19, 2024Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/²⁷
• Jun 17, 2024Granted 163,334 shares of TerrAscend Corp.²⁸
• Apr 19, 2024Exercised options 13,797 shares of HERON THERAPEUTICS, INC. /DE/²⁹
• Apr 3, 2024Exercised options 62,500 shares of HERON THERAPEUTICS, INC. /DE/³⁰